SOCAM Development Ltd
HKEX:983
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
SOCAM Development Ltd
Capital Expenditures
SOCAM Development Ltd
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SOCAM Development Ltd
HKEX:983
|
Capital Expenditures
-HK$11m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
8%
|
|
C
|
China State Construction International Holdings Ltd
HKEX:3311
|
Capital Expenditures
-HK$565.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-4%
|
C
|
Chi Kan Holdings Ltd
HKEX:9913
|
Capital Expenditures
-HK$1.9m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Golden Ponder Holdings Ltd
HKEX:1783
|
Capital Expenditures
-HK$9.6m
|
CAGR 3-Years
-241%
|
CAGR 5-Years
-240%
|
CAGR 10-Years
N/A
|
|
C
|
Central Holding Group Co Ltd
HKEX:1735
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
G
|
Grand Ming Group Holdings Ltd
HKEX:1271
|
Capital Expenditures
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is SOCAM Development Ltd's Capital Expenditures?
Capital Expenditures
-11m
HKD
Based on the financial report for Dec 31, 2023, SOCAM Development Ltd's Capital Expenditures amounts to -11m HKD.
What is SOCAM Development Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
8%
Over the last year, the Capital Expenditures growth was 42%. The average annual Capital Expenditures growth rates for SOCAM Development Ltd have been 21% over the past three years , 13% over the past five years , and 8% over the past ten years .